Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
INDUSTRY
×
peginterferon alfa-2b
×
Clear all
Filters
3
NCT02089685
2022-09-13
MK-3475-029
Merck Sharp & Dohme LLC
Phase 1/2
Completed
295 enrolled
25 charts